Delivery Order SPE2DR25D1202-SPE2DR26F75RT
Award Date 3/6/26
Potential Completion Date 3/9/26
Potential Value $9.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $9,379.16 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides global pharmaceutical support across multiple therapeutic domains to military healthcare programs. Place of performance is Conshohocken, PA. The order was awarded on a firm...
- The Defense Logistics Agency issued a $5,957.71 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999.00 and extending through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order carries firm...
- The Defense Logistics Agency issued a $9,331.28 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Actemra Actpen 162 mg/0.9 mL pharmaceutical product. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure and has an ultimate completion date of March 3, 2026. No set-aside was used. The delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that...
- The Defense Logistics Agency issued a $5,237.78 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Actemra Actpen 162 mg/0.9 mL pharmaceutical supply. The order is placed against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The ultimate...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 4, 2026, with a ceiling value of $96,241.41, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. Place of performance is Conshohocken, PA. The order carries an ultimate completion date of March 5, 2026, and is priced on a firm fixed-price basis with no set-aside applied. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 vehicle through...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 6, 2026, with a ceiling value of $1,501.74 for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector units. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999 through December 2026), which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $3,884.56 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for ACTEMRA 162 mg/0.9 mL syringes under a firm fixed-price arrangement. The order will be completed by March 9, 2026. Place of performance is Conshohocken, PA. The delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999 and running through December 2026....
- The Defense Logistics Agency issued a $12,709.81 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for ACTEMRA 162 mg/0.9 mL syringes, with an ultimate completion date of March 2, 2026. The order is issued under an Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of...
- <p>The Defense Logistics Agency issued a $3,010.67 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Actemra 162 mg/0.9 mL syringes.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of March 9, 2026.</p>
- The Defense Logistics Agency issued a $10,674.71 delivery order to Amerisourcebergen Drug Corp on February 3, 2026, for Actemra 162 mg/0.9 ml syringe supply. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 4, 2026, and is priced on a firm fixed-price basis with no set-aside applied. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a single-award indefinite delivery contract valued at $999,999,999.00 and running...